COMMUNIQUÉS West-GlobeNewswire

Tevogen Delivers Stronger Second Quarter and First Half 2025 Financial Results with Reduced Expenses and Growth Momentum
19/08/2025
Expenses significantly lower with expansion on multiple efforts; Q2 2025 loss from operations reduced to $5.4 million vs $8.6 million in Q2 2024. Tevogen maximizes capital efficiency, maintains access to financing to [...]

Pages